Goal templates — Pharmacovigilance (Drug Safety) — P5

Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) · P5 — Expert Professional

These are canon-derived frames, not advice: every line is either verbatim JobFrame canon text or a fixed template wrapping it. ⟨target⟩ / ⟨baseline⟩ / ⟨date⟩ are placeholders for the manager to fill in. Nothing here is generated by AI — rows are omitted, never invented, when the canon lacks the underlying field.

SMART goals

One row per canon core output / responsibility this level owns.

JFM responsibility (P5)

Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives

Specific: Deliver: "Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives"
Measurable: Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
Achievable: Scoped to this level's jfm complexity/problem-solving rubric: "Resolves intangible safety questions independently, balancing epidemiology, RWE, and statistics to shape risk-minimisation strategy."
Relevant: Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P5 — Expert Professional.
Time-bound: ⟨date⟩

JFM responsibility (P5)

Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy

Specific: Deliver: "Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy"
Measurable: Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
Achievable: Scoped to this level's jfm complexity/problem-solving rubric: "Resolves intangible safety questions independently, balancing epidemiology, RWE, and statistics to shape risk-minimisation strategy."
Relevant: Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P5 — Expert Professional.
Time-bound: ⟨date⟩

JFM responsibility (P5)

Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership

Specific: Deliver: "Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership"
Measurable: Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
Achievable: Scoped to this level's jfm complexity/problem-solving rubric: "Resolves intangible safety questions independently, balancing epidemiology, RWE, and statistics to shape risk-minimisation strategy."
Relevant: Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P5 — Expert Professional.
Time-bound: ⟨date⟩

JFM responsibility (P5)

Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums

Specific: Deliver: "Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums"
Measurable: Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
Achievable: Scoped to this level's jfm complexity/problem-solving rubric: "Resolves intangible safety questions independently, balancing epidemiology, RWE, and statistics to shape risk-minimisation strategy."
Relevant: Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P5 — Expert Professional.
Time-bound: ⟨date⟩

JFM responsibility (P5)

Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments

Specific: Deliver: "Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments"
Measurable: Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
Achievable: Scoped to this level's jfm complexity/problem-solving rubric: "Resolves intangible safety questions independently, balancing epidemiology, RWE, and statistics to shape risk-minimisation strategy."
Relevant: Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P5 — Expert Professional.
Time-bound: ⟨date⟩

Copy / print as textshow ▾

1. Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives  [source: JFM responsibility (P5)]
   Specific:    Deliver: "Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives"
   Measurable:  Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
   Achievable:  Scoped to this level's jfm complexity/problem-solving rubric: "Resolves intangible safety questions independently, balancing epidemiology, RWE, and statistics to shape risk-minimisation strategy."
   Relevant:    Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P5 — Expert Professional.
   Time-bound:  ⟨date⟩

2. Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy  [source: JFM responsibility (P5)]
   Specific:    Deliver: "Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy"
   Measurable:  Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
   Achievable:  Scoped to this level's jfm complexity/problem-solving rubric: "Resolves intangible safety questions independently, balancing epidemiology, RWE, and statistics to shape risk-minimisation strategy."
   Relevant:    Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P5 — Expert Professional.
   Time-bound:  ⟨date⟩

3. Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership  [source: JFM responsibility (P5)]
   Specific:    Deliver: "Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership"
   Measurable:  Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
   Achievable:  Scoped to this level's jfm complexity/problem-solving rubric: "Resolves intangible safety questions independently, balancing epidemiology, RWE, and statistics to shape risk-minimisation strategy."
   Relevant:    Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P5 — Expert Professional.
   Time-bound:  ⟨date⟩

4. Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums  [source: JFM responsibility (P5)]
   Specific:    Deliver: "Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums"
   Measurable:  Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
   Achievable:  Scoped to this level's jfm complexity/problem-solving rubric: "Resolves intangible safety questions independently, balancing epidemiology, RWE, and statistics to shape risk-minimisation strategy."
   Relevant:    Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P5 — Expert Professional.
   Time-bound:  ⟨date⟩

5. Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments  [source: JFM responsibility (P5)]
   Specific:    Deliver: "Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments"
   Measurable:  Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
   Achievable:  Scoped to this level's jfm complexity/problem-solving rubric: "Resolves intangible safety questions independently, balancing epidemiology, RWE, and statistics to shape risk-minimisation strategy."
   Relevant:    Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P5 — Expert Professional.
   Time-bound:  ⟨date⟩

OKRs

Objectives from this level's core outputs; key results only where a real dimension or capability backs them.

JFM responsibility (P5)

Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives

From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives"
Evidence at this level's scope bar: "Multiple systems or a technical domain" — ⟨target⟩ by ⟨date⟩

JFM responsibility (P5)

Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy

From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy"
Evidence at this level's autonomy bar: "Sets direction within the domain" — ⟨target⟩ by ⟨date⟩

JFM responsibility (P5)

Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership

From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership"
Evidence at this level's complexity bar: "Novel, high-ambiguity problems; establishes the approach" — ⟨target⟩ by ⟨date⟩

JFM responsibility (P5)

Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums

From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums"
Evidence at this level's impact bar: "Org / multi-team outcomes" — ⟨target⟩ by ⟨date⟩

JFM responsibility (P5)

Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments

From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments"
Evidence at this level's decision rights bar: "Authority over a technical domain" — ⟨target⟩ by ⟨date⟩

Copy / print as textshow ▾

Objective 1: Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives  [source: JFM responsibility (P5)]
  KR1. From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives"
  KR2. Evidence at this level's scope bar: "Multiple systems or a technical domain" — ⟨target⟩ by ⟨date⟩

Objective 2: Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy  [source: JFM responsibility (P5)]
  KR1. From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy"
  KR2. Evidence at this level's autonomy bar: "Sets direction within the domain" — ⟨target⟩ by ⟨date⟩

Objective 3: Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership  [source: JFM responsibility (P5)]
  KR1. From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership"
  KR2. Evidence at this level's complexity bar: "Novel, high-ambiguity problems; establishes the approach" — ⟨target⟩ by ⟨date⟩

Objective 4: Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums  [source: JFM responsibility (P5)]
  KR1. From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums"
  KR2. Evidence at this level's impact bar: "Org / multi-team outcomes" — ⟨target⟩ by ⟨date⟩

Objective 5: Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments  [source: JFM responsibility (P5)]
  KR1. From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments"
  KR2. Evidence at this level's decision rights bar: "Authority over a technical domain" — ⟨target⟩ by ⟨date⟩

MBO areas

Key result areas from this level's responsibilities, each with a standard grounded in the canon leveling rubric where one exists.

Area	Standard	Target	Due
Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives	Consistent with this level's jfm knowledge-application rubric: "Brings expert benefit-risk and risk-management mastery to strategic, often ambiguous safety issues spanning multiple products or a therapeutic area."	⟨target⟩	⟨date⟩
Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy	Consistent with this level's jfm knowledge-application rubric: "Brings expert benefit-risk and risk-management mastery to strategic, often ambiguous safety issues spanning multiple products or a therapeutic area."	⟨target⟩	⟨date⟩
Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership	Consistent with this level's jfm knowledge-application rubric: "Brings expert benefit-risk and risk-management mastery to strategic, often ambiguous safety issues spanning multiple products or a therapeutic area."	⟨target⟩	⟨date⟩
Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums	Consistent with this level's jfm knowledge-application rubric: "Brings expert benefit-risk and risk-management mastery to strategic, often ambiguous safety issues spanning multiple products or a therapeutic area."	⟨target⟩	⟨date⟩
Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments	Consistent with this level's jfm knowledge-application rubric: "Brings expert benefit-risk and risk-management mastery to strategic, often ambiguous safety issues spanning multiple products or a therapeutic area."	⟨target⟩	⟨date⟩

Copy / print as textshow ▾

1. Area: Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives  [source: JFM responsibility (P5) — reused, no distinct responsibility content]
   Standard: Consistent with this level's jfm knowledge-application rubric: "Brings expert benefit-risk and risk-management mastery to strategic, often ambiguous safety issues spanning multiple products or a therapeutic area."
   Target:   ⟨target⟩   Due: ⟨date⟩

2. Area: Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy  [source: JFM responsibility (P5) — reused, no distinct responsibility content]
   Standard: Consistent with this level's jfm knowledge-application rubric: "Brings expert benefit-risk and risk-management mastery to strategic, often ambiguous safety issues spanning multiple products or a therapeutic area."
   Target:   ⟨target⟩   Due: ⟨date⟩

3. Area: Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership  [source: JFM responsibility (P5) — reused, no distinct responsibility content]
   Standard: Consistent with this level's jfm knowledge-application rubric: "Brings expert benefit-risk and risk-management mastery to strategic, often ambiguous safety issues spanning multiple products or a therapeutic area."
   Target:   ⟨target⟩   Due: ⟨date⟩

4. Area: Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums  [source: JFM responsibility (P5) — reused, no distinct responsibility content]
   Standard: Consistent with this level's jfm knowledge-application rubric: "Brings expert benefit-risk and risk-management mastery to strategic, often ambiguous safety issues spanning multiple products or a therapeutic area."
   Target:   ⟨target⟩   Due: ⟨date⟩

5. Area: Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments  [source: JFM responsibility (P5) — reused, no distinct responsibility content]
   Standard: Consistent with this level's jfm knowledge-application rubric: "Brings expert benefit-risk and risk-management mastery to strategic, often ambiguous safety issues spanning multiple products or a therapeutic area."
   Target:   ⟨target⟩   Due: ⟨date⟩

Scorecard

Only perspectives with real canon backing are shown — no Financial or Customer perspective, since nothing in the canon grounds business-financial or customer measures for a role alone.

Internal process

"Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives"→ ⟨target⟩ by ⟨date⟩
"Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy"→ ⟨target⟩ by ⟨date⟩
"Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership"→ ⟨target⟩ by ⟨date⟩
"Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums"→ ⟨target⟩ by ⟨date⟩
"Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments"→ ⟨target⟩ by ⟨date⟩

Role calibration

Meets the scope bar: "Multiple systems or a technical domain"→ ⟨target⟩ by ⟨date⟩
Meets the autonomy bar: "Sets direction within the domain"→ ⟨target⟩ by ⟨date⟩
Meets the complexity bar: "Novel, high-ambiguity problems; establishes the approach"→ ⟨target⟩ by ⟨date⟩
Meets the impact bar: "Org / multi-team outcomes"→ ⟨target⟩ by ⟨date⟩
Meets the decision rights bar: "Authority over a technical domain"→ ⟨target⟩ by ⟨date⟩
Meets the leadership bar: "Leads cross-team technical initiatives"→ ⟨target⟩ by ⟨date⟩

Copy / print as textshow ▾

Internal process
  - "Drives PV strategy across multiple products or a therapeutic area, acting independently on signal-to-benefit-risk decisions that contribute to company safety objectives"  →  ⟨target⟩ by ⟨date⟩   [source: JFM responsibility (P5)]
  - "Owns benefit-risk reassessment when new risks emerge, integrating real-world evidence, epidemiology, and disproportionality analysis to guide risk-minimisation strategy"  →  ⟨target⟩ by ⟨date⟩   [source: JFM responsibility (P5)]
  - "Develops and manages risk management plans and post-marketing safety studies in collaboration with safety physicians and risk management leadership"  →  ⟨target⟩ by ⟨date⟩   [source: JFM responsibility (P5)]
  - "Serves as PV scientific spokesperson in interactions with EMA/national competent authorities and at safety governance forums"  →  ⟨target⟩ by ⟨date⟩   [source: JFM responsibility (P5)]
  - "Builds influential cross-functional networks and supervises scientists on complex or high-visibility safety assignments"  →  ⟨target⟩ by ⟨date⟩   [source: JFM responsibility (P5)]

Role calibration
  - Meets the scope bar: "Multiple systems or a technical domain"  →  ⟨target⟩ by ⟨date⟩   [source: level dimension (Scope)]
  - Meets the autonomy bar: "Sets direction within the domain"  →  ⟨target⟩ by ⟨date⟩   [source: level dimension (Autonomy)]
  - Meets the complexity bar: "Novel, high-ambiguity problems; establishes the approach"  →  ⟨target⟩ by ⟨date⟩   [source: level dimension (Complexity)]
  - Meets the impact bar: "Org / multi-team outcomes"  →  ⟨target⟩ by ⟨date⟩   [source: level dimension (Impact)]
  - Meets the decision rights bar: "Authority over a technical domain"  →  ⟨target⟩ by ⟨date⟩   [source: level dimension (Decision rights)]
  - Meets the leadership bar: "Leads cross-team technical initiatives"  →  ⟨target⟩ by ⟨date⟩   [source: level dimension (Leadership)]